Hawash Yousry
Department of Medical Parasitology, NLI, Menoufia University, Shebin El-Koom, Menoufia, Egypt. ; Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Al-Taif University, Al-Taif, Saudi Arabia.
Korean J Parasitol. 2014 Jun;52(3):263-71. doi: 10.3347/kjp.2014.52.3.263. Epub 2014 Jun 26.
PCR detection of intestinal protozoa is often restrained by a poor DNA recovery or by inhibitors present in feces. The need for an extraction protocol that can overcome these obstacles is therefore clear. QIAamp® DNA Stool Mini Kit (Qiagen) was evaluated for its ability to recover DNA from oocysts/cysts directly from feces. Twenty-five Giardia-positive, 15 Cryptosporidium-positive, 15 Entamoeba histolytica-positive, and 45 protozoa-free samples were processed as control by microscopy and immunoassay tests. DNA extracts were amplified using 3 sets of published primers. Following the manufacturer's protocol, the kit showed sensitivity and specificity of 100% towards Giardia and Entamoeba. However, for Cryptosporidium, the sensitivity and specificity were 60% (9/15) and 100%, respectively. A series of optimization experiments involving various steps of the kit's protocol were conducted using Cryptosporidium-positive samples. The best DNA recoveries were gained by raising the lysis temperature to the boiling point for 10 min and the incubation time of the InhibitEX tablet to 5 min. Also, using a pre-cooled ethanol for nucleic acid precipitation and small elution volume (50-100 µl) were valuable. The sensitivity of the amended protocol to Cryptosporidium was raised to 100%. Cryptosporidium DNA was successfully amplified by either the first or the second primer set. When applied on parasite-free feces spiked with variable oocysts/cysts counts, ≈ 2 oocysts/cysts were theoretically enough for detection by PCR. To conclude, the Qiagen kit with the amended protocol was proved to be suitable for protozoan DNA extraction directly from feces and support PCR diagnosis.
肠道原生动物的聚合酶链反应(PCR)检测常常受到DNA回收率低或粪便中存在抑制剂的限制。因此,显然需要一种能够克服这些障碍的提取方案。对QIAamp® DNA粪便迷你试剂盒(Qiagen公司)从粪便中直接从卵囊/包囊中回收DNA的能力进行了评估。通过显微镜检查和免疫测定试验,将25份贾第虫阳性、15份隐孢子虫阳性、15份溶组织内阿米巴阳性和45份无原生动物的样本作为对照进行处理。使用3组已发表的引物对DNA提取物进行扩增。按照制造商的方案,该试剂盒对贾第虫和阿米巴的敏感性和特异性均为100%。然而,对于隐孢子虫,敏感性和特异性分别为60%(9/15)和100%。使用隐孢子虫阳性样本对该试剂盒方案的各个步骤进行了一系列优化实验。通过将裂解温度提高到沸点10分钟以及将InhibitEX片剂的孵育时间延长到5分钟,获得了最佳的DNA回收率。此外,使用预冷乙醇进行核酸沉淀和小体积洗脱(50 - 100微升)也很有价值。改进后的方案对隐孢子虫的敏感性提高到了100%。隐孢子虫DNA通过第一组或第二组引物成功扩增。当应用于接种了不同数量卵囊/包囊的无寄生虫粪便时,理论上约2个卵囊/包囊就足以通过PCR检测。总之,经改进方案的Qiagen试剂盒被证明适用于直接从粪便中提取原生动物DNA并支持PCR诊断。